Night shift workers (four outside)
Release time:
2020-09-11
Night Shift Worker (Four Outer Songs)
Wang Junxiao
Night Shift Worker
# September Stars ThinNight Plenty
Hidden from Tower
Hanging Yellow Mud Leg
and Half Cigarette Head
# to the looming
in the structure
Like the stunned limestoneon the ground, a pestle
, the world knows that it does not speak
, but it does not know how many whispers
in its heart. It was also soft soil
and fine sand on the bottom of the sea
. When it passed by the window
, the more it grew
, the harder and the silence
silent
wind
wind fell a few children
some gathered up the mountain
some in the lane
some edible grass body water dew
some fell cheeks red
how many years back and forth
this fairy tale, the shoulder injury of the old man
on the slate repeatedly beaten by
without knowing it is as dazzling as the sun
dark brown skin and trembling smoke gun
you just washed out the empty mountain in early summer
a rain
south wind is short of breath and holds the hair tip
thunder sound
dragonfly stops on green plantain
White Butterfly Play Xiaolian
Rolling New Green Up to the Sky
Drunk is Iraqi
Looking Back and Laughing All Sling
You happened to be in early summer
Unfortunately
Secret
I woke up from my dream this morning
World Passed by my window
the red and green
in front of the door is wine with rose petals
I dare not get drunk
only sip
and
under the rotating starry sky
only carrying lanterns, knock open doors
on the way to find a place to return
sip
this is the secret of March
I only tell you that spring in Pu 'er is beautiful
only tell you that flowers bloom
tell you clean sky and tall and straight peaks
tell you night breeze and setting sun
tell you and I almost shed tears
In fact, I don't want to write about spring
, nor do I want to write about those romantic and snowy moons
Looking at the world
is not as good as you
This is my secret
I don't say
Untitled
Love
is Lake Clear
the sky reflected on the water
the boat sails on the cloud
the sun hides in the pebbles
I walk in the water
reaches out to catch the spring breeze
and then you scoop me up on the shore
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31